Correlation Between Black Diamond and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Black Diamond and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Anebulo Pharmaceuticals.
Diversification Opportunities for Black Diamond and Anebulo Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Black and Anebulo is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Black Diamond i.e., Black Diamond and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Black Diamond and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 1.68 times more return on investment than Anebulo Pharmaceuticals. However, Black Diamond is 1.68 times more volatile than Anebulo Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 214.00 in Black Diamond Therapeutics on November 3, 2024 and sell it today you would earn a total of 48.00 from holding Black Diamond Therapeutics or generate 22.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Black Diamond Therapeutics vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Black Diamond Therap |
Anebulo Pharmaceuticals |
Black Diamond and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Black Diamond and Anebulo Pharmaceuticals
The main advantage of trading using opposite Black Diamond and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world |